Table 3. Treatment choice after EGFR test in patients with different EGFR mutation.
| EGFR | Treatment choice after EGFR test, n (%) | ||||||
|---|---|---|---|---|---|---|---|
| BSC | Chemo | Chemo + RT | RT | Surgery | TKI | TKI + RT | |
| Negative | 27 (14.67) | 85 (46.20) | 12 (6.52) | 17 (9.24) | 5 (2.71) | 37 (20.11) | 1 (0.54) |
| Sensitizing | 5 (8.93) | 9 (16.07) | 1 (1.79) | 2 (3.57) | 0 (0) | 37 (66.07) | 2 (3.57) |
| Resistance | 3 (33.33) | 3 (33.33) | 0 (0) | 0 (0) | 1 (11.11) | 2 (22.22) | 0 (0) |
| Combination | 0 (0) | 1 (20.00) | 0 (0) | 0 (0) | 0 (0) | 4 (80.00) | 0 (0) |
EGFR, epidermal growth factor receptor; BSC, best supportive care; chemo, chemotherapy; RT, radiotherapy; TKI, tyrosine kinase inhibitor.